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The widespread use of sulphur mustard (SM) as an incapacitating chemical warfare agent in the
past century has proved its long-lasting toxic effects. It may also be used as a chemical terrorist
agent. Therefore, all health professionals should have sufficient knowledge and be prepared for
any such chemical attack. SM exerts direct toxic effects on the eyes, skin, and respiratory tissue,
with subsequent systemic action on the nervous, immunological, haematological, digestive, and
reproductive systems. SM is an alkylating agent that affects DNA synthesis, and, thus, delayed
complications have been seen since the First World War. Cases of malignancies in the target
organs, particularly in haematopoietic, respiratory, and digestive systems, have been reported.
Important delayed respiratory complications include chronic bronchitis, bronchiectasis, frequent
bronchopneumonia, and pulmonary fibrosis, all of which tend to deteriorate with time. Severe dry
skin, delayed keratitis, and reduction of natural killer cells with subsequent increased risk of infections
and malignancies are also among the most distressing long-term consequences of SM intoxication.
However, despite a lot of research over the past decades on Iranian veterans, there are still major
gaps in the SM literature. Immunological and neurological dysfunction, as well as the relationship
between SM exposure and mutagenicity, carcinogenicity, and teratogenicity are important fields
that require further studies, particularly on Iranian veterans with chronic health effects of SM
poisoning. There is also a paucity of information on the medical management of acute and delayed
toxic effects of SM poisoningFa subject that greatly challenges health care specialists.
History
Synthesis
Sulphur mustard (SM) or mustard gas is bis(2-chloroethyl)
sulphide and was first synthesised in 1822 by Despretz. Its
vesicant properties were noted by Guthrie in 1860.
1 In 1886,
Victor Meyer was the first to prepare pure SM by the reaction
of thiodiglycol with phosphorus trichloride. Thiodiglycol
was prepared by the reaction of 2-chloroethanol with
potassium sulphide. Thiodiglycol can also be prepared by
the American process, in which ethylene oxide reacts with
hydrogen sulphide. SM was produced for use as a chemical
warfare agent (CWA) by what is known as the Leveinstein
process: the reaction of ethylene with sulphur dichloride
before the First World War (WWI).
2
Applications
SM has been the most widely used CWA in the past century.
It was employed extensively in the WWI between 1914 and
1918. In spite of the Geneva Protocol in 1925 on the
prohibition of CWA, SM was used by Italian troops in
Ethiopia (1935–1936) and by Egyptian forces in Yemen
(1963–1967). Recently, the greatest use of SM was by the
Iraqi Army against Iranian soldiers and even civilians in
Sardasht and Halabjah between 1983 and 1988, resulting in
over 100,000 chemical casualties.
3
Although there have been no substantiated reports
of the use of SM by terrorist groups, the simplicity of its
chemical synthesis does offer the potential for use by
terrorists.
Type of exposure
Single
Most human cases of SM poisoning have occurred during
armed conflicts and most accidents were a single exposure.
4
Multiple
Multiple, low, SM exposure occurred occupationally and
during the WWI and in the Iran–Iraq conflict.
4,5
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First-aid workers, nursing, and medical staff who were
looking after SM casualties in the field clinics and hospitals
during the Iraq–Iran war without proper personal physical
protection have become intoxicated. Some of them are now
suffering from the delayed toxic effects of SM and have
disabilities of between 5 and 25%.
6
Sub-clinical
Sub-clinical exposure to SM in some Iranian combatants
induced delayed toxic effects. A study on 77 subjects, who
were present in a contaminated area and had no acute
symptoms or signs at the time of exposure, are now suffering
from respiratory disorders such as bronchiectasis and
bronchiolitis obliterans.
7
Chronic
Chronic SM exposure is usually occupational. Some factory
workers in Japan and in the UK were reported to have had SM
poisoning and even malignancies due to SM.
8,9
Routes of exposure
Inhalation
Inhalation is the major route of exposure that induces
respiratory and systemic toxicity following absorption across
the lung surface.
10
Dermal
SM is a vesicant or blistering agent that has direct toxic
effects on the skin producing erythema, blistering, epider-
molysis, and necrosis. It is a lipid-soluble compound and
thus can be readily absorbed across the skin.
2,11
Ocular
The eyes are the most sensitive organs to SM. This marked
susceptibility is attributable to several ocular features
including the aqueous–mucous surface of the cornea and
conjunctiva, as well as the high turnover rate and intense
metabolic activity of the corneal epithelial cells.
5,12,13
Oral
SM may also enter the body by oral ingestion. We observed a
few Iranian combatants during the war who had ingested
food contaminated by SM and who subsequently became
intoxicated. They experienced nausea, vomiting, haematem-
esis, abdominal pain, and dyspnoea. SM may also be
absorbed through the lower gastrointestinal tract.
14
Injections
Injection is a very rare route of SM intoxication and has not
been reported.
Toxicity
Supra-acute
Exposure to very high doses of SM in the field may
induce convulsions and death in less than 1h.
15,16 Such
observations have not been reported during the Iraq–Iran
war.
Acute
Acute toxic effects generally appear after variable periods of
latency depending on the dose, mode of exposure, the
environmental temperature, and probably on the indivi-
dual.
2,17,18
Sub-acute
Sub-acute exposure occurred during the Iran–Iraq war and in
the workers in the SM munitions factories. However, this
type of exposure may present as a mild, acute SM intoxica-
tion or as a complication in the respiratory tract or even as
malignancy.
6
Delayed
Delayed toxic effects of SM have been documented. The first
report of delayed toxic effects in Iranian veterans was
reported in 1986.
19 Several articles on the delayed toxic
effects and complications of SM in Iranian veterans have
been published since.
6,7,10,11,13
Chronic
Several studies suggest that workers who were chemically
exposed to mustard agents in the British and Japanese
munitions factories developed chronic respiratory effects. In
a cohort mortality study of 3500 workers at a manufacturing
plant in England, a statistically significant increase in the
number of deaths due to influenza, pneumonia, bronchitis,
and asthma were reported. This was present even among
those with fewer than 3 years of employment at the plant
and so was not related to the duration of employment.
20
A 25-year follow-up study of workers exposed to SM in a
Japanese production plant revealed that more highly
exposed workers had more chronic bronchitis and a slightly
lower forced expiratory volume in one second/forced vital
capacity (FEV1/FVC) ratio than either the less-exposed or an
unexposed group of their co-workers.
9 In another study,
Brown
8 reported a large number of employees who worked at
the Huntsville Arsenal in Alabama. They were continuously
exposed to the gas over long periods of time and developed
bronchiectasis with progressive emphysema and narrow
attenuated bronchioles.
8 Cancer of the respiratory system
has also been associated with occupational exposure to SM
and is discussed later in this article.
Toxicodynamics
Monofunctional mustards have one alkylating site and there-
fore can attack and break the DNA at specific nucleotides.
Although SM reacts with RNA, proteins, and phospholipids,
the consensus view is that a DNA alkylate, plays an important
role in delayed toxic effects.
21,22 The major alkylating site of
nucleic acids of mammalian origin is the nitrogen residue of
guanine.
23 Cell death from DNA cross-linking is delayed until
the cell replicates its DNA or undergoes division. At higher
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cross-linking become important and produce more rapid cell
death. The acute damage to the cornea, mucous membranes,
and skin seen after SM exposure is probably generated by one
or more of these other mechanisms. One mechanism that
may be involved in acute damage is nicotinamide adenine
dinucleotide (NAD) depletion. Other potential mechanisms of
cell death are related to rapid inactivation of sulphydryl-
containing proteins and peptides, such as glutathione. These
sulphydryl compounds are critical in maintaining the appro-
priate oxidation–reduction state of cellular components.
Glutathione is also thought to be critical in reducing reactive
oxygen species in the cell and preventing peroxidation and
loss of membrane integrity.
24,25
Toxicokinetics
SM is absorbed by inhalation, through the skin, or through
the anterior surface of the eye. It may also be absorbed
through the gastrointestinal tract following consumption of
contaminated food. When delivered as liquid or vapour, the
skin plays a very important role as a port of entry for SM. SM
undergoes hydrolysis producing half-mustard and thiodigly-
col, which is the major metabolite and is excreted in urine.
From the total mustard that penetrates, only 10–20% is
fixed to macromolecules in skin. The remaining 80–90% is
rapidly transported away from the site of absorption by the
circulation.
26–28 In terminally ill cancer patients, 80–90% of
the radioactivity of the injected
14C-labelled SM disappeared
after several minutes from the blood and was excreted
mainly in the urine within 24h.
29 SM is eliminated in a
two-compartment model. The distribution of SM is quick
with a long terminal half-life (5.56min and 3.59h). The
volume of distribution at steady state (Vdss) is 74.4l.
30
Whole body autographic studies with
35S-labelled SM have
shown that elevated radioactivity was detected in the nasal
region, followed by the kidneys, liver, and intestines at all
times studied after percutaneous or intravenous administra-
tion.
31 In humans, unhydrolysed SM can be present in brain
and fat depots days after exposure.
32 Few data are available
on biotransformation of SM in man. Two studies in
rats revealed that conjugation with glutathione is more
important than hydrolysis.
29,33 More recent investigations
demonstrated that 60% of the dose is excreted within 24h in
the urine.
30
Mutagenicity
There is no evidence for the mutagenicity of SM and no
evidence of teratogenicity was found in rats treated with
different doses of SM.
17,34
Carcinogenicity
SM is classified as a carcinogen by the International Agency
for Cancer Research. Human studies indicated a causal
association between occupational exposure to SM and the
excessive occurrence of respiratory cancer, skin cancer, and,
possibly, leukaemia.
35 A significant excess of deaths (33 cases
against 0.9 expected) due to respiratory cancer was found
among former workers of the Japanese poison gas factory
that operated from 1929 to 1945.
36 Similarly, highly
significant excesses in cancer of the larynx, pharynx, and
other upper respiratory sites were observed in former
employees of a British plant that manufactured SM. A
moderate, but still significantly higher mortality than
normal population was also observed in lung cancer.
37
Gastric cancer, basal cell carcinoma, Bowen’s disease,
Bowen’s carcinoma, and skin spinocellulare have all been
reported following occupational exposure to mustard
gas.
20,38,39
Effects on reproductive system
A few studies are available regarding the reproductive effects
of SM. Intravenous injection of SM in male mice results in
damage to the testes, with inhibition of spermatogenesis.
40
Nevertheless, the damage is usually transient, because
testicular recovery is observed at two weeks, with the
formation of mature sperms four weeks after exposure. A
two-generation study of rats indicated that exposure to SM at
levels of 0.03, 0.1, and 0.4mg/kg/day did not have any
adverse effects on reproductive performance or the fertility of
male or female rats throughout two consecutive generations,
except for an altered sex ratio in the 0.4-mg/kg group.
34
Target organs
Eyes
Eyes are the most sensitive organs to SM. The first symptoms
of SM exposure are usually those on the eyes.
5,12,13
Respiratory tract
Next to the eye lesions, the greatest discomfort produced by
mustard gas results from irritation and toxicity of the
respiratory system. Respiratory effects occur in a dose-
dependent manner from the nasal mucosa to the terminal
bronchioles
5,10,41
Dermis
Direct toxic effects of SM on the skin are the main apparent
effects that lead to it being called a vesicant or blistering
agent. A German medical toxicologist and an Iranian
medical toxicologist (first author) classified the cutaneous
mustard gas lesions as follows:
  erythematous form;
  pigmentary exfoliation;
  superficial vesicular to bullous form;
  bullous necrotisation;
  deep necrotising non-bullous form; and
  allergic and toxic contact reactions of the skin.
Different forms of the above cutaneous lesions may be
observed in one patient. The pigmentary exfoliative form is
often combined with severe lung damage.
42
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Gastrointestinal effects after SM exposure have been docu-
mented in some studies. Destruction of the mucosa and
shedding of the epithelial elements, however, begin days
after exposure, resulting in loss of large volumes of fluid and
electrolytes.
40,43 Acute gastroduodenitis with haemorrhagic
erosions, acute desquamative enteritis, and severe haemor-
rhagic necrotic colitis were reported in the WWI veterans
44
but not observed in the Iranian veterans.
Central nervous system
Extremely heavy exposure to SM can cause central nervous
system (CNS) excitation leading to convulsions in animals.
15
Balali-Mood and Navaeian
19 reported convulsions in six
Iranian veterans who were hospitalised during the early
stages of their intoxication. Most casualties from the WWI
and from the Iran–Iraq conflict, however, revealed mild and
very non-specific neurological effects such as headache,
anxiety, fear of the future, restlessness, confusion, and
lethargy.
19
Peripheral nervous system
A frequent long-term complication in patients exposed to
SM is delayed neuropathic symptoms, which are under-
represented in most previous studies.
45
Haematopoietic system
As an alkylating agent, SM is particularly toxic to rapidly
proliferating cells such as lymphoid and bone marrow cells.
Leukocytosis is common within the first few days after
exposure. White blood cell counts then begin to drop on the
third and fourth days after exposure and reach their
minimum level around the ninth day. This leukopaenia is
followed by a decrease in megakaryocytes and finally in the
erythropoietic series.
46–49 Bone marrow biopsies have shown
hypocellular marrow and atrophy involving all elements.
14 If
cytopaenia is not marked and there are still remaining stem
cells, recovery will take place as the patient recovers.
15 The
bone marrow studies reveal a severe decrease in cellularity
and fat replacement, and nuclear changes, such as budding,
double nuclear, and kariorrhexis in erythrocyte precursors.
The toxic effects of SM on the haematopoietic system are
dose dependent, and it is concluded that SM causes aplastic
or ineffective haematopoiesis.
50 Severe leukopaenia, how-
ever, is an ominous sign, leading to secondary infections and
higher mortality rates in these patients. SM victims with
white blood cell counts of 200cells/ml or less died during
their initial admissions.
46 Aplastic anaemia in seven patients
with SM poisoning six to 12 months after exposure was also
reported.
2
Immune system
SM poisoning can result in the impairment of both humoral
and cellular immune functions.
46,49,51 Along with the
appearance of clinical disorders, both C3 and C4 titres
showed an increase, followed by a gradual decrease over one
year. The majority of SM-exposed patients had increased
levels of immunoglobulin (Ig)-G and IgM during the first
weeks and up to the sixth month after exposure.
52
Depression of cell-mediated immunity has been observed
in the Iranian veterans one, two, and three years after
exposure.
53 Natural killer cells, which are known to be one of
the most important components of the cellular immunity,
have been found to be significantly lower in patients with
severe respiratory complications 10 years after exposure.
54 In
a controlled study, the number of natural killer cells was still
significantly lower 16–20 years after exposure.
6,49
Endocrine system
SM may affect several different target organs comprising the
endocrine system. The total and free testosterone levels were
markedly decreased in the first 5 weeks after SM exposure,
but all returned to normal by the twelfth week after
exposure. A significant diminished sperm count in 77 SM
veterans three to nine years after exposure have been
reported.
34 Another study showed that 66% of 42 men
examined one to three years after SM exposure had sperm
counts of less than 3 million cells/ml and their follicle-
stimulating hormone levels were higher than normal men.
2
Clinical effects
Acute
The first contact with SM is usually painless and only a garlic
or sulphur odour can be noticed. Normally, a symptom-free
interval is observed for several hours. The duration of this
interval correlates inversely with the absorbed dose of the
agent. Eyes, skin, and the respiratory system are the three
major targets for the local toxic effects of SM.
Initial clinical symptoms and signs occur in the eyes about
onehour after exposure, starting with a sensation of
grittiness, a progressive soreness, and a bloodshot appear-
ance, proceeding to acute conjunctivitis. After several hours,
the corneal epithelium begins to vesicate and slough, leading
to severe pain, blepharospasm, and decreased visual acuity.
Gradual spontaneous recovery usually occurs after 48hours,
with full regeneration of the corneal epithelium within four
to five days. Complete symptomatic recovery, however, may
take six weeks or longer.
5,12,13,16 Skin effects commence with
erythema a few hours after exposure with no itching or pain
leading to blister formation and further lesions within hours
and days later as mentioned above.
52
Respiratory symptoms usually occur earlier than skin
lesion with dyspnoea, coughing, and chest discomfort
progressing to acute rhinopharingo tracheobronchitis. In
severe cases, bronchopneumonia, adult respiratory distress
syndrome, and even pulmonary emboli may develop causing
mortality mostly in the second week after exposure.
5,14,16
The symptoms of systemic poisoning are very similar to
those caused by radio- or chemotherapy. Low-dose exposure
may result in headache, nausea, vomiting, and loss of
appetite. Higher dose exposure may damage more severely
the gastrointestinal tract and the bone marrow. This may
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weakness, and, in very severe cases, excitation of the CNS
with convulsions.
2,55 The maximum intensity of symptoms
can be reached after days. An exposure to large doses of SM
can cause damage to the haematopoietic and the immune
system.
49,50
Delayed
During the Iran–Iraq war, about 100,000 people suffered from
SM exposure and now after 20 years, around 40,000 veterans
have complained of delayed effects.
4,6,56 The first report of
delayed toxic effects in Iranian veterans was reported in 1986
as mentioned above.
19 The most prominent late clinical effects
were observed in the respiratory tract (78%), neuropsychiatrics
systems (45%), skin (41%), and eyes (36%).
19,38
Chronic
Chronic occupational exposure to SM is discussed above.
The majority of clinical symptoms and signs were observed
in the respiratory tract, presenting as coughing with or
without productions, dyspnoea, wheezing, and bronchial
rale. Chronic bronchitis, obstructive, and restrictive lung
diseases leading to chronic obstructive pulmonary disease
and bronchiectasis have been reported.
6 Malignancies,
particularly in the respiratory tract and haematopoietic
system, may occur.
Complications
It is very difficult to differentiate between the delayed toxic
effects and complications of SM poisoning. However,
complications may be defined as the persistent, permanent,
and life-threatening delayed toxic effects of SM. Long-term
complications of SM are discussed below.
Identification
Environmental
Environmental identification of SM in the field is of great
medical importance to confirm the diagnosis, and to
evaluate and decontaminate those exposed. Decontamina-
tion of the environment also requires agent identification.
Air
Identification of SM in the air is now possible using portable
detectors, special biosensors that are available in some
advanced chemical defence laboratories. It is also possible
to quantify SM concentration in the air using a portable gas
chromatograph–mass spectrometer.
57
Soil
SM is a very stable compound and has been identified in the
soil many months, and even years, after exposure under
particularly cold environmental conditions. SM and its
hydrolysis products including half-mustard and thiodiglycol
can be identified and quantified by the specific and sensitive
analytical methods such as gas chromatography–mass
spectrometry (GC–MS).
58
Water
SM is insoluble in water and its hydrolysis in the environ-
ment is very slow. However, identification of SM in water is
possible in advanced environmental and CBRN defence
laboratories by GC–MS.
57
Patients
Alkylation products of SM with DNA and proteins (for
example, haemoglobin and albumin), as well as its urinary
metabolites, have been proven to be useful targets for the
diagnosis of SM exposure in humans. Urinary markers are
readily accessible, although their rapid elimination
limits their use for retrospective detection. Adducts with
macromolecules such as proteins offer longer lasting
biological markers for exposure to SM, possibly up to several
months.
59
Blood
The primary site of DNA alkylation by SM is the N7 position
of deoxyguanosine residues.
60 Upon depurination of the
resulting N7-(2-hydroxyethylthioethyl)-0-20-deoxyguano-
sine, N7-(2-hydroxyethylthioethyl) guanine (N7-HETE-Gua)
is obtained. Although GC–MS analysis has proved proble-
matic, N7-HETE-Gua can be conveniently analysed using
liquid chromatography–mass spectrometry.
61 The adduct
can be detected in urine, and also after processing of skin
and blood samples of animals exposed to SM. An enzyme-
linked immunosorbent assay (ELISA) has been successfully
developed using monoclonal antibodies raised against N7-
HETE-guanosine-50-phosphate coupled to keyhole limpet
haemocyanin.
62
This method was applied to blood samples from two
casualties of the Iran–Iraq War, collected 22 and 26 days
following the alleged exposure to SM.
63 The alkylation of
proteins by SM mainly occurs in carboxyl, amino, and
sulphydryl groups, as well as in the nitrogens of the
imidazole ring of histidine. Definitive evidence of specific
alkylation sites can be obtained by using modern mass
spectrometric (MS) techniques. Although MS methods can
be used to confirm the diagnosis under more sophisticated
conditions, the ELISA approach has been mainly
developed for use under field conditions. Haemoglobin
and albumin are two abundant proteins in human blood
that can be readily isolated for the determination of SM
adducts.
2,59
Urine
Although the hydrolysis product of SM, namely thiodiglycol,
is only a minor metabolite, the sulphoxide derivative of
thiodiglycol is abundantly present in the urine and can be
reduced to thiodiglycol for GC–MS analysis.
63
Unfortunately, both thiodiglycol and its sulphoxide, are
not unequivocal markers of poisoning in humans, and low
concentrations are present in normal human urine.
64–67
The -lyase metabolites, which are derived from an initial
reaction of SM with glutathione, are unequivocal biomarkers
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GC–MS analysis.
68 This method has been applied to urine
samples from two human casualties accidentally exposed to
the agent and from five Iranian casualties of CWattacks. The
-lyase metabolites were detected in one sample collected 13
days after the alleged SM exposure.
68,69
Blister fluid
Analysis of the vesicle fluid for thiodiglycol may confirm a
suspected SM exposure. The fluid contained in the vesicles is
not toxic and presents no risk to the attending medical
staff.
70
Tissue
The DNA adduct can also be detected in skin of human
exposed as it was done after processing in animals exposed to
SM.
62 Organ tissues of the post-mortem samples taken from
chemical Iranian martyrs revealed SM with different con-
centrations in different organs.
31,32
Post mortem
Toxicological analyses of the post-mortem samples (blood,
urine, and organ tissues) of two Iranian chemical gassed
combatants who died in Belgian hospitals, revealed SM.
32
The detailed biological fate of SM in Iranian chemical
poisoned patients who were hospitalised in British hospitals
including post-mortem toxicological analyses reported.
71
Ethical considerations
All studies performed by the authors in this review followed
the standard ethics. They were all confirmed by the
University Medical Research Ethics Committee and were
carried out after written informed consent of the patients
was obtained. Figure 2 is from a patient whose consent for
publication has been obtained.
Long-term complications
Information on the long-term effects of SM comes from two
major lines of investigations: studies of soldiers who were
exposed to the agent on the battlefield, and studies of
workers who were employed in mustard gas factories
(occupational exposure). Although long-term effects after
battlefield exposure are referred to as ‘late’ or ‘delayed’
complications, the term ‘chronic’ is more suitable for the
complications caused by occupational exposure. It must also
be emphasised that delayed effects generally occur some
months or years after a single or brief exposure and are not
the same as chronic poisoning, which comes from contin-
uous intake of the poison over a relatively long period of
time. The first report on the delayed toxic effects of SM
poisoning in 236 Iranian veterans revealed that the most
common effects were on the respiratory tract (78%), CNS
(45%), skin (41%), and the eyes (36%). These effects were
recorded between two and 28 months after exposure.
21
Comparison of early (one week after exposure) and late (2
years after exposure) toxic effects of SM poisoning in 77 CWA
victims indicated that eye lesions do not change signifi-
cantly, dermal complications tend to decrease, and respira-
tory complications generally deteriorate over the years.
72 In
a study on 34,000 Iranians, 13–20 years after exposure to SM,
the most common complications were found in the lungs
(42.5%), the eyes (39%), and the skin (24.5%).
23 In a group of
40 severely intoxicated Iranian veterans in Mashhad, 16–20
years after their initial exposure, the most commonly
affected organs were lungs (95%), peripheral nerves
(77.5%), skin (75%), and eyes (65%) as shown in Figure 1.
Respiratory
Respiratory problems are the greatest cause of long-term
disability among people with combat exposure to mustard
gas. A triad of cough, expectoration, and dyspnoea has
been found to be present in more than 80% of Iranian
veterans three years after their initial exposure.
24 Haemop-
tysis (mainly streaky), chest tightness, chest pain, and
nocturnal dyspnoea are also frequent. The main objective
clinical findings are generalised wheezing (the most com-
mon sign), crackles, decreased lung sounds, clubbing, and
cyanosis.
6,25
Pulmonary function testing has revealed more obstructive
patterns than restriction and about half of these obstructive
spirometric results are reversible in response to inhaled
bronchodilators. FVC, FEV1, and FEV1/FVC (FEV1%) have all
been found to be significantly lower in SM-intoxicated
veterans compared with healthy unexposed individuals
and CWA survivors who had used a gas mask at the time of
attack.
24 Abnormal spirometric findings, in general, and
restrictive patterns, in particular, tend to increase over
time.
2,19,73 A study on 77 subjects, who were present in a
contaminated area and had no acute signs and symptoms at
the time of exposure, but now have respiratory disorders,
indicates that sub-clinical exposure to SM can be responsible
for the occurrence of delayed respiratory complications such
38
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Figure 1 Frequency of delayed complications of SM in different organs of 40
Iranian veterans in Mashhad.
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7 Chest radio-
graph findings in patients with late respiratory complica-
tions of SM have been described as increased
bronchovascular markings, hyperinflation, bronchiectasis,
pneumonic infiltration, and radiological evidence of pul-
monary hypertension.
19,74 However, chest radiographs are
not sensitive enough for the detection of respiratory
complications in these patients and high-resolution com-
puted tomography of the chest may be required as the
diagnostic imaging procedure of choice.
75 A study of 197
Iranian veterans 10 years after a single heavy exposure to SM
revealed the development of a series of delayed destructive
pulmonary sequelae such as chronic bronchitis (58%),
asthma (10%), bronchiectasis (8%), large airway narrowing
(9%), and pulmonary fibrosis (12%).
71
Chronic bronchitis
Several studies have reported chronic bronchitis as the most
common late complication of the respiratory system result-
ing from war exposure to mustard gas.
7,76,77 Hypoxaemia
and hypercapnoea are commonly observed in moderate to
severe cases, leading to cor pulmonale and respiratory failure
in the final stages of the disease.
78,79 Infection of the
respiratory tract, resulting in bronchopneumonia, is also a
common problem, often complicated by septicaemia.
80
Asthma
Airway hypersensitivity, manifested as typical attacks of
breathlessness, wheezing, and nocturnal cough, as well as a
reversible obstructive pattern on pulmonary function tests,
have been reported between four weeks to 20 years after SM
inhalation. Patients with chronic bronchitis may also have
some degree of bronchospasm, which does not respond to
bronchodilators. Attacks of bronchospasm are characteristi-
cally triggered by respiratory infections, environmental
allergens, and cold weather.
77,78
Bronchiectasis
Direct effects of SM on the bronchial wall mucosa and, more
recurrent, respiratory infections following SM inhalations
are known to be responsible for the development of
bronchiectasis. Both the severity and frequency of bronch-
iectatic lesions tend to increase over the long-term follow-
ups, as evidenced by a study of 40 Iranian veterans with
severe late complications of SM poisoning. These lesions
usually begin bilaterally in the lower lobes and then progress
towards the middle lobe and the lingula. In severe cases with
extensive bronchiectatic lesions, pulmonary hypertension,
and ultimately cor pulmonale may occur.
7,78,81
Large airway narrowing
Airway narrowing, due to scarring or granulation tissue, is a
late sequel of acute injuries to the trachea and large bronchi,
usually developing two years after exposure.
6,82,83 A study of
19 Iranian veterans with large airway narrowing due to SM,
revealed stenosis in the trachea (seven patients), main
bronchi (eight patients), and lobar bronchi (four patients).
77
In contrast to stenosis caused by prolonged intubations,
there is no predilection in the right main bronchus.
78,82 The
major problem in these patients is the recurrence of the
lesion, which usually occurs 6 months after treatment.
83
Pulmonary fibrosis
Late-onset pulmonary fibrosis has been reported in several
Iranian veterans with combat exposure to SM.
77,78 The
analysis of bronchoalveolar lavage fluid from patients with
mustard gas inhalation showed that these patients have an
ongoing local inflammatory process of the lower respiratory
tract resulting in the development of pulmonary fibrosis
years after the initial exposure. Histopathological examina-
tion of transbronchial lung biopsies (TBLBs) of SM-exposed
veterans revealed variegated fibrosis, diffuse fibrosis, and an
absence of fibrosis in 86, 4, and 10% of the patients,
respectively. Usual interstitial pneumonitis accounted for
97% of all cases of fibrosis.
84 In another study, electron
microscopic examination of seven TBLB specimens was
carried out in a WHO research centre in Japan. Abnormal
findings included proliferation, desquamation, and degen-
eration of the bronchial epithelial cells; interstitial fibrosis or
fibrosing alveolitis; and an increased type I and type II
alveolar epithelial cells as well as hyperplasia of ciliated and
goblet cells.
85 Inflammation and fibrotic processes in the
lung tissue of SM-exposed patients may be progressive.
56
Diffusing capacity of the lung could be used as an objective
monitor of the degree of fibrosis and also as a good predictor
of prognosis.
77
Dermal
The occurrence and persistence of lesions following SM
exposure is directly related to the duration and severity of
exposure. Injury that results in erythema and oedema
without vesicle formation is almost always followed by a
complete healing and no residual effects.
2,86 Blistering and
necrotic wounds, however, cause permanent residual effects.
The first report of delayed toxic effects of SM poisoning two
years after exposure, in 236 Iranian veterans, revealed late
skin effects such as hyperpigmentation (34%), hypopigmen-
tation (16%), and dermal scarring (8%).
19 The most common
skin complaint among these patients was itching followed
by a burning sensation and desquamation. These symptoms
are basically owing to dryness of the skin and thus become
worse in dry weather and after physical activity. A more
recent study of 40 Iranian veterans, who were heavily
exposed to the gas 16–20 years previously, revealed the most
common cutaneous lesions as hyperpigmentation, erythe-
matous papular rash, dry skin, multiple cherry angiomas,
atrophy, hypopigmentation, and hypertrophy. These lesions
were found on the genital areas (48%), the back (48%), the
front thorax and abdomen (44%), the lower extremities
(mainly inguinal) (44%), the upper extremities (mainly
auxiliary) (41%), and the head and neck (15%). Dry skin
was more prominent in the extremities. Hyperpigmentation
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moid, which is a diffuse hyperpigmented area with super-
imposed macular hypo- and hyperpigmentations.
6,11
In another study, the cutaneous lesions of 500 SM-exposed
Iranian veterans were compared with that of 500 unexposed
veterans. An association was found between SM exposure
and late skin lesions such as severe dry skin, hyper- and
hypopigmentation, local hair loss, eczema, and chronic
urticaria. There was also a higher incidence of vitiligo,
psoriasis, and discoid lupus erythematosus among SM-
poisoned patients. This could be due to the immunological
basis of these disorders and the fact that SM has adverse long-
term effects on the immune system. Previously injured sites
have been reported to be sensitive to subsequent mechanical
injury and showed recurrent blistering after mild injury.
87
Histopathological examination of skin biopsies has re-
vealed non-specific findings including epidermal atrophy,
keratosis, and basal membrane hyperpigmentation. Non-
specific fibrosis and melanophages have also been observed
within the dermis.
6,11,78,87 Areas (head and neck) of hyper-
and hypopigmentations of a patient two years after SM
exposure are shown in Figure 2. Occupational exposure to
SM has been demonstrated to cause a variety of skin changes,
including pigmentary disorders, skin ulcers, and cutaneous
cancers.
88
Ophthalmological
In less than 1% of patients with battlefield exposure to SM, a
delayed type of ulcerative keratopathy may develop, leading
to late-onset blindness.
89–92 The maximum delayed toxic
effects usually occur 15–20 years after initial exposure,
although latency periods as long as 40 years or as short as
six years have also been reported.
13,93,94 Patients are usually
symptom free for an indefinite number of years when
delayed keratitis develops, characterised by photophobia,
lacrimation, and failing vision.
92
In acute stages, the limbal region frequently presents a
marbled appearance in which porcelain-like areas of ischae-
mia are surrounded by blood vessels of irregular diameter.
Later, vascularised scars of the cornea are covered with
crystal and cholesterol deposits, leading to a worsening of
the opacification, recurrent ulcerations, and sometimes,
corneal perforation. Opacification of the cornea is seen
predominantly in the lower and central portions, whereas
the upper part is often protected by the eyelid.
92,94 Surpris-
ingly, lesions even recur after corneal transplantation.
93 The
exact pathogenesis of this condition is unknown, but
degenerative processes and immune reactions against cor-
neal proteins (collagen–mustard compound) have been
suggested as the cause of long-term damage.
94 Unfortu-
nately, there has been no report on any long-term studies on
mustard gas workers to determine their ocular status after
prolonged occupational exposure.
Neuropsychiatric conditions
Casualties from WWI and from Iran–Iraq conflict were noted
to have long-term mood and anxiety disorders, as well as
post-traumatic stress disorder.
95,96 Debility, loss of vitality,
impaired concentration, sensory hypersensitivity, dimin-
ished libido, weakened potency, neuralgic complaints, and
disorders in autonomic regulation are the common mani-
festations. Neuropsychiatric evaluation of 1428 Iranian
veterans, three to nine years after exposure to SM, revealed
anxiety (15%), depression (46%), personality disorders
(31%), convulsions (6%), and psychosis (3%).
38 Disorders
of consciousness (27%), attention (54%), emotion (98%),
behaviour (80%), thought process (14%), and memory (80%)
were studied in 70 patients, three to five years after SM
exposure.
97 Depression and post-traumatic stress in Iranian
survivors of chemical warfare, mostly SM exposure, were also
reported.
98 In another study, decreased libido and impotence
were recorded in 52 and 9% of the patients, respectively.
Interestingly, 10% of the patients revealed an increased
libido. Functional photophobia, functional aphonia, and
effort syndrome have also been reported.
6
Neuromuscular conditions
Electromyography (EMG) and nerve conduction velocity
(NCV), on 40 Iranian veterans with severe late manifesta-
tions of SM poisoning, revealed abnormalities in the
peripheral nervous system of 77.5% of the patients. NCV
disturbances were more common in sensory nerves com-
pared with motor nerves and more prevalent in the lower
extremities than in the upper extremities. EMG recordings
revealed a normal pattern in 24 (60%) patients, incomplete
interference with normal amplitude in six (15%) patients,
and incomplete interference with low amplitude in 10 (25%)
patients. NCV and EMG disturbances in both upper and
lower extremities were mostly symmetric.
78
Immunological and haematopoietic myelosuppression is
the most serious effect of SM. SM can cause long-term effects
on the immune system in patients with severe intoxication.
Figure 2 Hyperpigmentation of the blister sites in an Iranian veteran with
delayed complication of SM.
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increased risk of infections in these patients. Forty male
subjects (aged 43.879.8 years), who had confirmed SM
poisoning 16–20 years before the study, were investigated.
Significant changes of haematological and immunological
parameters in these patients compared with 25 normal
individuals are summarised in Table 1.
49
Mutagenicity
A two-generation study of rats indicated that mustard gas
was not teratogenic.
17,34 There has been no other report on
the teratogenicity of SM and no clear evidence of this
problem following human exposure, although there have
been some claims made.
Carcinogenicity
SM is genotoxic because of its reactions with DNA, which is
an important first step in carcinogenesis. Although most
cells possess effective DNA repair mechanisms, these are not
always effective in the case of SM damage. Alkylation of
O6-guanine by SM seems to be critical. O6-ethylthioethyl-
guanine is a poor substrate for the DNA repair enzyme
O6-alkylguanine-DNA alkyltransferase.
99 Therefore, this
O6-lesion may be the most important mutagenic lesion.
However, only limited data are available on the specific
mutations produced by SM. Mutations in a tumour suppres-
sor or an oncogene gene can favour a proliferate advantage
of a clonal cell. Notably, alterations in the p53 tumour
suppressor gene have been described in Japanese mustard gas
workers.
100
However, most of the lesions in this population were
similar to smoking-related mutations. Mutations in lympho-
cytes at the hypoxanthine phosphoribosyltransferase (hprt)
gene locus have also been reported.
101
Reproductive
The effects of SM exposure during pregnancy are unknown.
Data addressing the productive toxicities of SM in human
models are both lacking and contradictory.
102
Management
Specific
No specific antidote has been developed for the treatment of
SM. Sodium thiosulphate and N-acetylcysteine have been
considered, although the acute clinical efficacy of these
agents has yet to be established. Sodium thiosulphate
infusion (10%) may prevent the toxic manifestations of
SM, providing it is administered immediately after an
exposure and no later than 30min after exposure.
103,104
There is no specific treatment for the delayed toxic effects
and complications of SM in different target organs.
Supportive
Supportive care focuses on the prevention of infection and
reduction of pain. Given the range of chronic health effects
of SM, patients are best managed by multidisciplinary
clinical teams of specialists. Financial, social, and cultural
support together with health education to maintain a good
lifestyle is of great importance.
2
Conclusions and recommendations
The use of SM as an incapacitating warfare agent in the past
century, particularly in WWI and the Iraq–Iran conflict,
has proved its highly long-lasting toxic effects. This
experience may ensure further use of the agent in future
military and terrorist attacks. SM exerts its toxicity through a
number of postulated pathogenic mechanisms including
DNA alkylation, NAD depletion, and inactivation of glu-
tathione. The eyes, skin, and respiratory system are the three
major targets for the direct toxic effects of SM. When
absorbed in large amounts, it can also damage rapidly
proliferating cells of the bone marrow and cause severe
suppression of the immune system, as well as other systemic
toxicities such as neurological and digestive disorders. Even
more important is a wide range of chronic health effects
including chronic bronchitis, bronchiectasis, frequent
bronchopneumonia, and pulmonary fibrosis, all of which
tend to deteriorate in time. Severe dry skin, delayed keratitis,
and pathogenic status of cell-mediated immunity with a
subsequent increased risk of infections and even possible
malignancies are also among the most distressing long-term
consequences of SM intoxication. However, there are still
major gaps in SM literature and further studies on humans
exposed to the agent are required. Immunological and
psychological dysfunctions, as well as the relationship
between SM exposure, and carcinogenesis and teratogenesis
are important fields that require further investigation. There
is also a paucity of information regarding the medical
management of acute and delayed toxic effects of SM
poisoning, a subject that greatly challenges health care
specialists.
It is hoped that by the advancement of the Organization
for Prohibition of Chemical Weapons (OPCW), no CWA will
be used in the future. However, chemical terrorism involving
the use of SM remains a threat to human health globally.
Thus, further studies on this subject are recommended.
Table 1 Significant changes of haematological and immunological para-
meters in 40 patients with severe SM intoxication compared to 25 normal
individuals
Patient mean7s.d. Control mean7s.d. P-value
WBC (1000/mm
3) 7.2471.90 5.7971.12 0.025
RBC (million/mm
3) 5.4670.45 5.1970.28 0.035
Monocyte (%) 4.871.6 3.971.1 0.013
HCT (%) 48.373.5 45.571.9 0.047
IgM (mg/dl) 235.3784.8 136.8758.3 0.0001
C3 MIC (g/dl) 109.8730.1 90.9714.8 0.03
CD3 (%) 71.178.6 65.6710.7 0.037
CD16+5 (NK cells) 11.675.8 17.579.6 0.006
Abbreviations: HCT, haematocrit; Ig, immunoglobulin; MIC, minimum
inhibitory concentration; NK, natural killer; RBC, red blood cell; SM, sulphur
mustard; WBC, white blood cell.
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